Annual EBITDA
$2.49 M
+$2.15 M+646.62%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual EBITDA is $2.49 million, with the most recent change of +$2.15 million (+646.62%) on December 31, 2023.
- During the last 3 years, CPIX annual EBITDA has risen by +$4.04 million (+259.56%).
- CPIX annual EBITDA is now -77.61% below its all-time high of $11.10 million, reached on December 31, 2011.
Performance
CPIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$13.10 K
-$446.70 K-97.15%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly EBITDA is $13.10 thousand, with the most recent change of -$446.70 thousand (-97.15%) on September 30, 2024.
- Over the past year, CPIX quarterly EBITDA has increased by +$1.57 million (+100.84%).
- CPIX quarterly EBITDA is now -99.67% below its all-time high of $3.95 million, reached on June 30, 2011.
Performance
CPIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$1.42 M
-$527.50 K-58.92%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM EBITDA is -$1.42 million, with the most recent change of -$527.50 thousand (-58.92%) on September 30, 2024.
- Over the past year, CPIX TTM EBITDA has dropped by -$4.76 million (-142.68%).
- CPIX TTM EBITDA is now -112.24% below its all-time high of $11.62 million, reached on September 30, 2011.
Performance
CPIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CPIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +646.6% | +100.8% | -142.7% |
| 3 y3 years | +259.6% | +102.7% | -175.1% |
| 5 y5 years | +132.6% | +100.6% | +69.0% |
CPIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +389.8% | -99.5% | +100.4% | -136.4% | +52.2% |
| 5 y | 5-year | at high | +153.6% | -99.5% | +100.4% | -136.4% | +73.4% |
| alltime | all time | -77.6% | +132.6% | -99.7% | +100.3% | -112.2% | +81.3% |
Cumberland Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.10 K(-97.2%) | -$1.42 M(+58.9%) |
| Jun 2024 | - | $459.80 K(-236.6%) | -$895.30 K(-174.4%) |
| Mar 2024 | - | -$336.60 K(-78.4%) | $1.20 M(-63.9%) |
| Dec 2023 | $2.49 M(+646.6%) | -$1.56 M(-388.4%) | $3.33 M(+5.1%) |
| Sep 2023 | - | $540.60 K(-78.9%) | $3.17 M(-18.9%) |
| Jun 2023 | - | $2.56 M(+42.7%) | $3.91 M(+123.6%) |
| Mar 2023 | - | $1.79 M(-204.2%) | $1.75 M(+425.1%) |
| Dec 2022 | $332.90 K(-138.8%) | -$1.72 M(-234.7%) | $333.00 K(-127.4%) |
| Sep 2022 | - | $1.28 M(+220.8%) | -$1.22 M(-59.1%) |
| Jun 2022 | - | $398.20 K(+5.4%) | -$2.98 M(+114.3%) |
| Mar 2022 | - | $377.80 K(-111.6%) | -$1.39 M(+61.9%) |
| Dec 2021 | -$857.80 K(-44.9%) | -$3.27 M(+578.0%) | -$857.80 K(-145.3%) |
| Sep 2021 | - | -$482.30 K(-124.3%) | $1.90 M(-20.1%) |
| Jun 2021 | - | $1.99 M(+118.6%) | $2.37 M(>+9900.0%) |
| Mar 2021 | - | $908.70 K(-275.7%) | $15.00 K(-101.0%) |
| Dec 2020 | -$1.56 M(-66.4%) | -$517.30 K(+7620.9%) | -$1.56 M(-52.2%) |
| Sep 2020 | - | -$6700.00(-98.2%) | -$3.26 M(-39.0%) |
| Jun 2020 | - | -$369.70 K(-44.3%) | -$5.35 M(+4.4%) |
| Mar 2020 | - | -$664.10 K(-70.1%) | -$5.12 M(+11.6%) |
| Dec 2019 | -$4.64 M(-39.1%) | -$2.22 M(+6.2%) | -$4.59 M(-37.7%) |
| Sep 2019 | - | -$2.09 M(+1345.7%) | -$7.37 M(+18.8%) |
| Jun 2019 | - | -$144.70 K(+9.8%) | -$6.21 M(+2.1%) |
| Mar 2019 | - | -$131.80 K(-97.4%) | -$6.08 M(-20.3%) |
| Dec 2018 | -$7.63 M(+572.3%) | -$5.00 M(+439.7%) | -$7.63 M(+175.4%) |
| Sep 2018 | - | -$927.30 K(+5198.9%) | -$2.77 M(+43.8%) |
| Jun 2018 | - | -$17.50 K(-99.0%) | -$1.93 M(-32.8%) |
| Mar 2018 | - | -$1.68 M(+1038.3%) | -$2.87 M(+152.8%) |
| Dec 2017 | -$1.13 M(-197.1%) | -$147.30 K(+74.1%) | -$1.13 M(-11.9%) |
| Sep 2017 | - | -$84.60 K(-91.2%) | -$1.29 M(+215.6%) |
| Jun 2017 | - | -$958.60 K(-1805.7%) | -$408.10 K(-138.3%) |
| Mar 2017 | - | $56.20 K(-118.7%) | $1.07 M(-8.8%) |
| Dec 2016 | $1.17 M(-67.2%) | -$301.10 K(-137.9%) | $1.17 M(-47.6%) |
| Sep 2016 | - | $795.40 K(+54.3%) | $2.23 M(-3.2%) |
| Jun 2016 | - | $515.50 K(+225.0%) | $2.31 M(-25.7%) |
| Mar 2016 | - | $158.60 K(-79.2%) | $3.10 M(-13.0%) |
| Dec 2015 | $3.57 M | $762.40 K(-12.4%) | $3.57 M(-19.0%) |
| Sep 2015 | - | $869.90 K(-33.8%) | $4.40 M(-15.5%) |
| Jun 2015 | - | $1.31 M(+111.2%) | $5.21 M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $621.80 K(-61.1%) | $5.55 M(-4.3%) |
| Dec 2014 | $5.80 M(-355.6%) | $1.60 M(-4.9%) | $5.80 M(+165.7%) |
| Sep 2014 | - | $1.68 M(+1.8%) | $2.18 M(-418.4%) |
| Jun 2014 | - | $1.65 M(+89.6%) | -$685.50 K(-77.9%) |
| Mar 2014 | - | $870.50 K(-143.1%) | -$3.11 M(+36.9%) |
| Dec 2013 | -$2.27 M(-122.6%) | -$2.02 M(+70.0%) | -$2.27 M(-169.0%) |
| Sep 2013 | - | -$1.19 M(+53.8%) | $3.29 M(-57.8%) |
| Jun 2013 | - | -$772.00 K(-145.2%) | $7.79 M(-27.9%) |
| Mar 2013 | - | $1.71 M(-51.7%) | $10.80 M(+7.7%) |
| Dec 2012 | $10.02 M(-9.7%) | $3.54 M(+6.9%) | $10.02 M(+18.0%) |
| Sep 2012 | - | $3.31 M(+47.8%) | $8.50 M(-1.3%) |
| Jun 2012 | - | $2.24 M(+139.4%) | $8.61 M(-16.6%) |
| Mar 2012 | - | $935.60 K(-53.5%) | $10.32 M(-7.0%) |
| Dec 2011 | $11.10 M(+44.5%) | $2.01 M(-41.2%) | $11.10 M(-4.5%) |
| Sep 2011 | - | $3.42 M(-13.3%) | $11.62 M(+6.1%) |
| Jun 2011 | - | $3.95 M(+130.5%) | $10.95 M(+32.0%) |
| Mar 2011 | - | $1.71 M(-32.4%) | $8.29 M(+8.0%) |
| Dec 2010 | $7.68 M(+15.1%) | $2.53 M(-8.0%) | $7.68 M(+26.1%) |
| Sep 2010 | - | $2.75 M(+113.0%) | $6.09 M(+2.7%) |
| Jun 2010 | - | $1.29 M(+17.2%) | $5.93 M(+8.9%) |
| Mar 2010 | - | $1.10 M(+17.1%) | $5.44 M(-18.4%) |
| Dec 2009 | $6.67 M(-19.7%) | $941.70 K(-63.7%) | $6.67 M(-10.8%) |
| Sep 2009 | - | $2.59 M(+221.5%) | $7.48 M(+2.6%) |
| Jun 2009 | - | $806.60 K(-65.4%) | $7.29 M(-14.9%) |
| Mar 2009 | - | $2.33 M(+33.1%) | $8.57 M(+3.1%) |
| Dec 2008 | $8.31 M(+5.6%) | $1.75 M(-27.0%) | $8.31 M(+1.8%) |
| Sep 2008 | - | $2.40 M(+15.0%) | $8.16 M(+0.4%) |
| Jun 2008 | - | $2.09 M(+0.8%) | $8.13 M(-2.6%) |
| Mar 2008 | - | $2.07 M(+29.2%) | $8.35 M(+7.2%) |
| Dec 2007 | $7.87 M(+160.8%) | $1.60 M(-32.4%) | $7.80 M(+5.6%) |
| Sep 2007 | - | $2.37 M(+2.8%) | $7.38 M(+6.3%) |
| Jun 2007 | - | $2.31 M(+52.6%) | $6.94 M(+22.7%) |
| Mar 2007 | - | $1.51 M(+27.3%) | $5.66 M(+87.5%) |
| Dec 2006 | $3.02 M(+240.2%) | $1.19 M(-38.5%) | $3.02 M(+64.9%) |
| Sep 2006 | - | $1.93 M(+88.2%) | $1.83 M(-1891.7%) |
| Jun 2006 | - | $1.03 M(-191.0%) | -$102.10 K(-91.0%) |
| Mar 2006 | - | -$1.13 M | -$1.13 M |
| Dec 2005 | $887.10 K | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual EBITDA year-on-year change?
- What is Cumberland Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Cumberland Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM EBITDA year-on-year change?
What is Cumberland Pharmaceuticals annual EBITDA?
The current annual EBITDA of CPIX is $2.49 M
What is the all time high annual EBITDA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual EBITDA is $11.10 M
What is Cumberland Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, CPIX annual EBITDA has changed by +$2.15 M (+646.62%)
What is Cumberland Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of CPIX is $13.10 K
What is the all time high quarterly EBITDA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly EBITDA is $3.95 M
What is Cumberland Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, CPIX quarterly EBITDA has changed by +$1.57 M (+100.84%)
What is Cumberland Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of CPIX is -$1.42 M
What is the all time high TTM EBITDA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM EBITDA is $11.62 M
What is Cumberland Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, CPIX TTM EBITDA has changed by -$4.76 M (-142.68%)